Terms: = Breast cancer AND DDX3X, DDX14, 1654, ENSG00000215301, DBX, DDX3, HLP2
48 results:
1. TCTP regulates genotoxic stress and tumorigenicity via intercellular vesicular signaling.
Amson R; Senff-Ribeiro A; Karafin T; Lespagnol A; Honoré J; Baylot V; Banroques J; Tanner NK; Chamond N; Dimitrov JD; Hoebeke J; Droin NM; Job B; Piard J; Bommer UA; Choi KW; Abdelfatah S; Efferth T; Telerman SB; Geyer FC; Reis-Filho J; Telerman A
EMBO Rep; 2024 Apr; 25(4):1962-1986. PubMed ID: 38548973
[TBL] [Abstract] [Full Text] [Related]
2. Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis.
Metcalfe K; Huzarski T; Gronwald J; Kotsopoulos J; Kim R; Moller P; Pal T; Aeilts A; Eisen A; Karlan B; Bordeleau L; Tung N; Olopade O; Zakalik D; Singer CF; Foulkes W; Couch F; Neuhausen SL; Eng C; Sun P; Lubinski J; Narod SA;
Br J Cancer; 2024 Feb; 130(2):269-274. PubMed ID: 38030749
[TBL] [Abstract] [Full Text] [Related]
3. Cytosolic DNA accumulation promotes breast cancer immunogenicity via a STING-independent pathway.
Zhang J; Dai H; Huo L; Burks JK; McGrail DJ; Lin SY
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37907220
[TBL] [Abstract] [Full Text] [Related]
4. KLHL29-mediated ddx3x degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer.
Yao L; Hao Q; Wang M; Chen Y; Cao H; Zhang Q; Yu K; Jiang Y; Shao Z; Zhou X; Xu Y
Oncogene; 2023 Nov; 42(47):3514-3528. PubMed ID: 37845393
[TBL] [Abstract] [Full Text] [Related]
5. AZI2 mediates TBK1 activation at unresolved selective autophagy cargo receptor complexes with implications for CD8 T-cell infiltration in breast cancer.
Yeo SK; Haas M; Manupati K; Hao M; Yang F; Chen S; Guan JL
Autophagy; 2024 Mar; 20(3):525-540. PubMed ID: 37733921
[TBL] [Abstract] [Full Text] [Related]
6. Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review.
Chatterji S; Krzoska E; Thoroughgood CW; Saganty J; Liu P; Elsberger B; Abu-Eid R; Speirs V
Lancet Oncol; 2023 Feb; 24(2):e74-e85. PubMed ID: 36725152
[TBL] [Abstract] [Full Text] [Related]
7. breast cancer chemotherapy treatment monitoring based on serum sample Raman spectroscopy.
Torre-Gutiérrez LG; Martínez-Zérega BE; Oseguera-Galindo DO; Aguilar-Lemarroy A; Jave-Suárez LF; Torres-González LA; González-Solís JL
Lasers Med Sci; 2022 Dec; 37(9):3649-3659. PubMed ID: 36239879
[TBL] [Abstract] [Full Text] [Related]
8. Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent ddx3 inhibitor:-an in silico and in vitro approach.
Doneti R; Pasha A; Botlagunta M; Heena SK; Mutyala VVVP; Pawar SC
Med Oncol; 2022 Sep; 39(11):179. PubMed ID: 36048256
[TBL] [Abstract] [Full Text] [Related]
9. ddx3x functionally and physically interacts with Estrogen Receptor-alpha.
Pardeshi J; McCormack N; Gu L; Ryan CS; Schröder M
Biochim Biophys Acta Gene Regul Mech; 2022 Feb; 1865(2):194787. PubMed ID: 35121200
[TBL] [Abstract] [Full Text] [Related]
10. TRIM58 inactivates p53/p21 to promote chemoresistance via ubiquitination of ddx3 in breast cancer.
Wang J; Yang F; Zhuang J; Huo Q; Li J; Xie N
Int J Biochem Cell Biol; 2022 Feb; 143():106140. PubMed ID: 34954155
[TBL] [Abstract] [Full Text] [Related]
11. Psychological well-being and death anxiety among breast cancer survivors during the Covid-19 pandemic: the mediating role of self-compassion.
Yousefi Afrashteh M; Masoumi S
BMC Womens Health; 2021 Nov; 21(1):387. PubMed ID: 34732193
[TBL] [Abstract] [Full Text] [Related]
12. Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter study.
Gupta S; Biswas G; Babu S; Maksud TM; Lakshmaiah KC; Patel JG; Raja G; Boya RR; Patil P; Choudhury K; Bondarde SA; Neve RS; Bhat G; Mamillapalli G; Patel AA; Patel P; Joshi N; Bajaj V; Khan MA
Breast; 2021 Dec; 60():147-154. PubMed ID: 34624757
[TBL] [Abstract] [Full Text] [Related]
13. Cytoplasmic ddx3 as prognosticator in male breast cancer.
van der Pol CC; Moelans CB; Manson QF; Batenburg MCT; van der Wall E; Borel Rinkes I; Verkooijen L; Raman V; van Diest PJ
Virchows Arch; 2021 Oct; 479(4):647-655. PubMed ID: 33974127
[TBL] [Abstract] [Full Text] [Related]
14. Targeting ddx3x Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response.
Choi H; Kwon J; Cho MS; Sun Y; Zheng X; Wang J; Bouker KB; Casey JL; Atkins MB; Toretsky J; Han C
Cancer Res; 2021 Jul; 81(13):3607-3620. PubMed ID: 33941613
[TBL] [Abstract] [Full Text] [Related]
15. Long noncoding RNA LINC00673-v4 promotes aggressiveness of lung adenocarcinoma via activating WNT/β-catenin signaling.
Guan H; Zhu T; Wu S; Liu S; Liu B; Wu J; Cai J; Zhu X; Zhang X; Zeng M; Li J; Song E; Li M
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14019-14028. PubMed ID: 31235588
[TBL] [Abstract] [Full Text] [Related]
16. Discrimination of different cancer types clustering Raman spectra by a super paramagnetic stochastic network approach.
González-Solís JL
PLoS One; 2019; 14(3):e0213621. PubMed ID: 30861043
[TBL] [Abstract] [Full Text] [Related]
17. ddx3x RNA helicase affects breast cancer cell cycle progression by regulating expression of KLF4.
Cannizzaro E; Bannister AJ; Han N; Alendar A; Kouzarides T
FEBS Lett; 2018 Jul; 592(13):2308-2322. PubMed ID: 29782654
[TBL] [Abstract] [Full Text] [Related]
18. Enzymatic stimuli-responsive methotrexate-conjugated magnetic nanoparticles for target delivery to breast cancer cells and release study in lysosomal condition.
Nosrati H; Mojtahedi A; Danafar H; Kheiri Manjili H
J Biomed Mater Res A; 2018 Jun; 106(6):1646-1654. PubMed ID: 29441671
[TBL] [Abstract] [Full Text] [Related]
19. Targeting mitochondrial translation by inhibiting ddx3: a novel radiosensitization strategy for cancer treatment.
Heerma van Voss MR; Vesuna F; Bol GM; Afzal J; Tantravedi S; Bergman Y; Kammers K; Lehar M; Malek R; Ballew M; Ter Hoeve N; Abou D; Thorek D; Berlinicke C; Yazdankhah M; Sinha D; Le A; Abrahams R; Tran PT; van Diest PJ; Raman V
Oncogene; 2018 Jan; 37(1):63-74. PubMed ID: 28869602
[TBL] [Abstract] [Full Text] [Related]
20. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L
Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102
[TBL] [Abstract] [Full Text] [Related]
[Next]
